Lv41
500 积分 2025-02-20 加入
In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020
2天前
已完结
Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis
27天前
已完结
Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications
27天前
已完结
Eravacycline -Synergistic activity with other antimicrobials in carbapenem resistant isolates of Escherichia coli and Acinetobacter baumannii
1个月前
已完结
Efficacy of Eravacycline Versus Best Previously Available Therapy for Adults With Pneumonia Due to Difficult-to-Treat Resistant (DTR) Acinetobacter baumannii
1个月前
已完结
Use of Eravacycline for Acinetobacter baumannii Infections: A Case Series
1个月前
已完结
Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report
1个月前
已完结
Erratum to ‘In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum’ [Journal of Global Antimicrobial Resistance 24 (2021) 93-97]
1个月前
已完结
Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals
1个月前
已完结
Combination eravacycline therapy for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: A case series
2个月前
已完结
皖公网安备34019202002308
